Level Financial Advisors, Inc. Pfizer Inc Transaction History

Level Financial Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 22, 2024	SELL	$26.13 - $33.94 $8,831 - $11,471	-338 Reduced 71.61%	134 $3,000
Q3 2023 Oct 18, 2023	SELL	$32.09 - $37.51 $16,847 - $19,692	-525 Reduced 52.66%	472 $15,000
Q1 2023 Apr 10, 2023	SELL	$39.39 - $51.28 $748 - $974	-19 Reduced 1.87%	997 $40,000
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $793 - $1,035	19 Added 1.91%	1,016 $0
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $41,196 - $61,066	997 New	997 $59,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Level Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Level Financial Advisors, Inc. with notifications on news.